171 related articles for article (PubMed ID: 24131103)
1. Subretinal fibrosis and uveitis: a spectral domain OCT study of its evolution and the minimal therapeutic effect of the off-label treatment with ranibizumab.
Symeonidis C; Dastiridou A; Konidaris V; Brazitikos P; Androudi S
Ocul Immunol Inflamm; 2014 Dec; 22(6):497-500. PubMed ID: 24131103
[TBL] [Abstract][Full Text] [Related]
2. Gray hyper-reflective subretinal exudative lesions in exudative age-related macular degeneration.
Ores R; Puche N; Querques G; Blanco-Garavito R; Merle B; Coscas G; Oubraham H; Semoun O; Souied EH
Am J Ophthalmol; 2014 Aug; 158(2):354-61. PubMed ID: 24794284
[TBL] [Abstract][Full Text] [Related]
3. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
[TBL] [Abstract][Full Text] [Related]
4. Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema.
Acharya NR; Sittivarakul W; Qian Y; Hong KC; Lee SM
Retina; 2011 Oct; 31(9):1871-6. PubMed ID: 21716165
[TBL] [Abstract][Full Text] [Related]
5. A quantitative approach to identify morphological features relevant for visual function in ranibizumab therapy of neovascular AMD.
Roberts P; Mittermueller TJ; Montuoro A; Sulzbacher F; Munk M; Sacu S; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6623-30. PubMed ID: 25190663
[TBL] [Abstract][Full Text] [Related]
6. Super-dose anti-VEGF (SAVE) trial: 2.0 mg intravitreal ranibizumab for recalcitrant neovascular macular degeneration-primary end point.
Brown DM; Chen E; Mariani A; Major JC;
Ophthalmology; 2013 Feb; 120(2):349-54. PubMed ID: 23131717
[TBL] [Abstract][Full Text] [Related]
7. Characteristic spectral-domain optical coherence tomography findings of multifocal choroiditis.
Vance SK; Khan S; Klancnik JM; Freund KB
Retina; 2011 Apr; 31(4):717-23. PubMed ID: 21386760
[TBL] [Abstract][Full Text] [Related]
8. Morphometric features on enhanced depth imaging optical coherence tomography scans in idiopathic posterior uveitis or panuveitis.
Agrawal R; Arora R; Keane PA; Agarwal A; Pavesio C
Int Ophthalmol; 2018 Jun; 38(3):993-1002. PubMed ID: 28585111
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography angiography in unilateral multifocal choroiditis and panuveitis: A case report.
Lee LC; Huang KH; Chen YH; Lin HT; Hsu CC; Tai MC; Liang CM; Chen JT; Chen CL
Medicine (Baltimore); 2019 Jan; 98(4):e14259. PubMed ID: 30681623
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
[TBL] [Abstract][Full Text] [Related]
11. Correlation between fluorescein angiography and spectral-domain optical coherence tomography in the diagnosis of cystoid macular edema.
Jittpoonkuson T; Garcia PM; Rosen RB
Br J Ophthalmol; 2010 Sep; 94(9):1197-200. PubMed ID: 19965832
[TBL] [Abstract][Full Text] [Related]
12. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
[TBL] [Abstract][Full Text] [Related]
13. Retinal angiomatous proliferation responds safely to a double dose (1.0 mg) of ranibizumab.
Hsu TK; Liu JH; Lei J; Chao HM
Clin Exp Optom; 2013 Jan; 96(1):112-6. PubMed ID: 22830523
[TBL] [Abstract][Full Text] [Related]
14. Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy.
Golbaz I; Ahlers C; Stock G; Schütze C; Schriefl S; Schlanitz F; Simader C; Prünte C; Schmidt-Erfurth UM
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1599-605. PubMed ID: 21051733
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography-guided ranibizumab injection for cystoid macular edema in well-controlled uveitis: twelve-month outcomes.
Reddy AK; Cabrera M; Yeh S; Davis JL; Albini TA
Retina; 2014 Dec; 34(12):2431-8. PubMed ID: 25170857
[TBL] [Abstract][Full Text] [Related]
16. Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography.
Markomichelakis NN; Halkiadakis I; Pantelia E; Peponis V; Patelis A; Theodossiadis P; Theodossiadis G
Ophthalmology; 2004 May; 111(5):946-53. PubMed ID: 15121373
[TBL] [Abstract][Full Text] [Related]
17. MULTI-MODAL IMAGING IN DIFFUSE SUBRETINAL FIBROSIS WITH UVEITIS SYNDROME.
Moll-Udina A; Alba-Linero C; Llorenç V; Adán A
Retin Cases Brief Rep; 2023 Jan; 17(1):13-17. PubMed ID: 33394959
[TBL] [Abstract][Full Text] [Related]
18. Treatment of diffuse subretinal fibrosis uveitis with rituximab.
Cornish KS; Kuffova L; Forrester JV
Br J Ophthalmol; 2015 Feb; 99(2):153-4. PubMed ID: 24879811
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind, placebo-controlled clinical trial on the efficacy of 0.5% indomethacin eye drops in uveitic macular edema.
Allegri P; Murialdo U; Peri S; Carniglia R; Crivelli MG; Compiano S; Autuori S; Mastromarino A; Zurria M; Marrazzo G
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1463-70. PubMed ID: 24519421
[TBL] [Abstract][Full Text] [Related]
20. PRESUMED POSTERIOR UVEITIS RELATED TO EHRLICHIA EXPOSURE.
Raja H; Mercer RC; Bakri SJ
Retin Cases Brief Rep; 2016; 10(2):134-6. PubMed ID: 26352324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
